Clinical outcomes after relapse during rituximab-based maintenance in ANCA-associated vasculitis: A single-center retrospective cohort study
Makoto Yamaguchi, Hirokazu Sugiyama, Hiroshi Kinashi, Keisuke Kamiya, Genri Tagami, Masayoshi Toda, Takayuki Katsuno, Takahiro Imaizumi · 2026
Read Clinical outcomes after relapse during rituximab-based maintenance in ANCA-associated vasculitis: A single-center retrospective cohort study by Makoto Yamaguchi, Hirokazu Sugiyama, Hiroshi Kinashi, Keisuke Kamiya, Genri Tagami, Masayoshi Toda, Takayuki Katsuno, Takahiro Imaizumi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0357836.txt.
Description
Makoto Yamaguchi led a team of eight authors studying relapse in a vessel disease, published in PLOS ONE in 2026. ANCA-associated vasculitis attacks blood vessels and organs, and rituximab maintenance therapy is meant to keep it quiet. Some patients still relapse during that maintenance. The team reviewed outcomes after such relapses at a single center.
Yamaguchi's retrospective cohort shows what happened next for those patients and how they fared. Doctors facing a relapse on maintenance need exactly this: evidence on what the next move tends to achieve. Single-center studies are small, but they record real practice in detail. For a rare disease, each careful series adds to a shared picture no one center can build alone.
Catalog record
| CREATOR | Makoto Yamaguchi, Hirokazu Sugiyama, Hiroshi Kinashi, Keisuke Kamiya, Genri Tagami, Masayoshi Toda, Takayuki Katsuno, Takahiro Imaizumi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29501 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |